Treatment time can be cut by a third for most kids with TB
Tuberculosis treatment can be shortened from six to four months in 80% of children, according to findings from a landmark study. Amy green reports.
TB catch-up plan underway in WC but old challenges linger
In 2019 around 360 000 people in South Africa fell ill with tuberculosis (TB) and about 58 000 people died due to the disease, according to a World Health Organization Report released last week. The COVID-19 pandemic has exacerbated these already alarming numbers, with some TB patients stopping treatment during lockdown. Siyabonga Kamnqa looks at the plans the Western Cape Health Department has in place to get its TB programme back on track and finds old challenges still remain.
TB treatment time cut by a third
A new four-month treatment course for drug-sensitive tuberculosis (the most common form of TB by far) is as safe and effective as the current six-month treatment course that has been in use since the 1980s, according to findings from a large new study. Amy Green reports.
What is behind SA’s higher TB numbers?
A World Health Organization report published last week showed more people are falling ill with tuberculosis in South Africa than previously thought – but also that the country’s treatment success rate for dangerous drug-resistant forms of the disease have improved. Amy Green asks what’s behind these numbers.
Herd (Immunity) Today, Gone Tomorrow
There is much talk in South Africa about a ‘second wave’ of COVID-19. In Europe, it is much more than talk, with COVID-19 diagnoses, hospital admissions, and deaths, not to mention ‘restrictions’, all on the rise. Alex Welte places in perspective what we do and do not know about herd immunity and potential second waves.
IN-DEPTH: The slow motion race for a TB vaccine
In recent months, the world has seen unprecedented investment in new vaccines. Yet, while a COVID-19 vaccine proven to be safe and effective may be less than a year away, a new tuberculosis vaccine might only be ready to be rolled out in a decade, despite a massive head start over COVID-19. Amy Green takes a closer look at the race for a new vaccine for the world’s top infectious disease killer.
IN DEPTH: Power grab or tying loose ends? Experts respond to new health regulations
As Health Minister, Dr Zweli Mkhize’s proposed amendments to regulations on notifiable medical conditions came under fire in Parliament this week, some public health and medical law experts welcomed the proposed amendments to the regulations and even made some suggestions on how it could be improved. Alicestine October took an in-depth look at what is at stake.
WHO estimates 20% more TB cases in SA than previously thought
Around 20% more people are falling ill with tuberculosis (TB) in South Africa, than previously thought. This emerged from new estimates contained in the 2020 WHO World TB Report launched today.
The promise of HIV prevention injections and how they work
Antiretroviral (ARV) injections that may protect women from becoming HIV-positive, if proved to be safe and effective, will be a major step forward in the fight against the HIV pandemic. Siyabonga Kamnqa reports.
Interview: Dr Thembisile Xulu – the new CEO of SANAC
Dr Thembisile Xulu was recently appointed as the new CEO of the South African National AIDS Council (SANAC). On her second day in office, Bienne Huisman spoke to Xulu about her new role, her love of medicine, and growing up in a family of strong women.
COVID-19: The fascinating science of what happens in the lungs
People with COVID-19 and people with tuberculosis (TB) can experience similar symptoms such as coughing and breathing difficulties as both diseases affect the lungs. Exactly how these diseases affect the lungs, however, differs. Tiyese Jeranji spoke to a leading South African pulmonologist to learn more.
Competition Commission gets private healthcare reform ball rolling
A year after the Competition Commission released its Health Market Inquiry (HMI) report, there has been very little action in addressing the report’s findings. Now, a notice the Competition Commission sent to stakeholders in September suggests there may finally be some movement. Elri Voigt reports.